The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 4.00
Ask: 4.50
Change: -0.10 (-2.30%)
Spread: 0.50 (12.50%)
Open: 4.35
High: 4.35
Low: 4.25
Prev. Close: 4.35
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Precise Protect Limited

11 Apr 2023 07:00

RNS Number : 7050V
Tavistock Investments PLC
11 April 2023
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation. With the publication of this announcement, this information is now considered to be in the public domain.

 

Tavistock Investments Plc

("Tavistock" or the "Company")

 

Acquisition of Precise Protect Limited

 

11 April 2023

 

Tavistock (AIM:TAVI) is pleased to announce that it has today acquired the entire issued and to be issued share capital of Precise Protect Limited, a profitable and fast growing insurance and protection business based in Bangor, Northern Ireland (the "Transaction"). Precise Protect is regulated by the Financial Conduct Authority (the "FCA") and Tavistock has received change in control consent for the Transaction from the FCA.

 

Background

 

As announced by the Company previously, the current financial year is a period of transition for Tavistock as the Company focuses on the continued development of its innovative commercial operating model and replacement of the contribution from its investment management business, which was sold to Titan Wealth Holdings Limited in August 2021.

 

Key elements of Tavistock's innovative commercial operating model include:

 

· Automated adviser oversight and real-time risk management

· Integrated technology facilitating data mining and business intelligence

· The Tavistock Academy to augment recruitment and career development

· Multiple sources of lead generation (including affinities, distribution partners and client referrals)

· A "Tell Me How" financial portal for corporate and affinity clients

· Proven blueprint for successfully integrating acquisitions.

 

Acquisition of Precise Protect

 

Precise Protect has a network of over 200 advisers working with more than 37,000 UK clients, with an average age of under 40. Precise offers its clients a wide range of products (including life and critical illness cover, private medical insurance, personal injury and income protection), several of which were developed in-house and are unique to the firm. In the year ended 31 October 2022, Precise Protect reported a profit before taxation of £1.45 million on turnover of £6.5 million and net assets of £1.23 million.

 

Following the Transaction, the Tavistock group will have more than 400 advisers and other business introducers looking after over 110,000 private clients with estimated assets of over £5.0 billion, as well as 350 corporate and affinity clients with some 16,000 employees.

 

The total consideration for the Transaction (assuming the achievement of all performance related earn-outs) will amount to up to some £7.0 million. £250,000 of the consideration is to be settled through the issue of 3,571,429 new ordinary shares of 1 penny each in the capital of Tavistock Investments Plc at an issue price of 7p per share (the "Consideration Shares"), with the balance being settled in cash from the Company's existing cash resources and the Company drawing down from the acquisition debt facility provided by the Bank of Ireland.

 

£2.75 million of the cash consideration is being paid now, together with the issue of the Consideration Shares (conditional on admission to trading on AIM). The balance of the cash consideration, totalling up to some £4.0 million, is payable in three subsequent annual instalments, the value of each being linked to the future performance of the Precise Protect business.

 

Admission and total voting rights

 

An application has been submitted to the London Stock Exchange for the Consideration Shares to be admitted to trading on AIM and trading in the Consideration Shares is anticipated to commence at 7.00am on Thursday 13 April 2023 ("Admission").

 

Upon Admission, the Company's issued share capital will comprise of 560,429,005 ordinary shares of 1 penny each, with one voting right per share ("Ordinary Shares"). The Company does not hold any ordinary shares in treasury and therefore the total number of Ordinary Shares with voting rights in the Company is 560,429,005.

 

With effect from Admission, the above figure of 560,429,005 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Key anticipated synergies

 

Precise Protect is the first significant acquisition in the next phase of Tavistock's growth plan. Integration of Precise into the Tavistock group will provide opportunities for operational cost savings (e.g. software, systems and regulatory oversight). However, the most significant benefit to Tavistock will be Precise Protect's experienced and dedicated specialist team. Other key benefits include:

 

· 37,000+ clients providing financial advice leads for both desk based and face-to-face advice teams

· Upskilling mortgage and protection advisers to become IFAs through the Tavistock Academy.

 

Tony Close, Precise Protect's Managing Director, said: "Precise Protect's revenues and EBITDA have grown rapidly and we remain excited about its prospects. However, we are very pleased to be joining the Tavistock group which will enable us to offer a much wider range of services to our clients, as well as deliver a development pathway for advisers and career development opportunities for staff."

 

Brian Raven, Tavistock's Chief Executive, said; "We are delighted to welcome Tony and his team into the group and to add Precise Protect's products to the wider group's service proposition. We look forward to benefitting from numerous synergies, including operational cost savings, increased profitability and new business leads."

 

 

For further information:

 

 Tavistock Investments Plc

 Oliver Cooke

 Brian Raven Tel: 01753 867000

 

Allenby Capital Limited

(Nominated adviser and broker)

Corporate Finance:

Nick Naylor, Nick Athanas, Daniel Dearden-Williams

Sales and Corporate Broking:

Tony Quirke

 

Tel: 020 3328 5656

Powerscourt

Gilly Lock

Roxane Girard

 

 

Tel: 07711 380 007

020 7250 1446

 

 About Tavistock Investments Plc

 

Tavistock Investments Plc is an AIM listed financial services group which before the acquisition of Precise Protect had more than 200 advisers and other business introducers across the UK. Tavistock has over 75,000 clients with more than £5 billon of investments. 

 

Tavistock's advisory business operates throughout the UK. The Tavistock Partners network supports Registered Individuals (self-employed IFAs), providing compliance, administration, technology, training and accounting services. The Tavistock Partnership is a network that does the same for Appointed Representative firms. Tavistock Private Client provides wealth management and financial planning to high-net-worth individuals.

 

The Tavistock Platform, launched in 2020, provides a low-cost platform service to the Group's advisory and investment clients.

 

Tavistock Asset Management ("TAM") markets the Group's centralised investment proposition, both the ACUMEN UCITS funds and the Group's Model Portfolio Service ("MPS"). In June 2021 the Company entered a ten-year strategic partnership with Titan Wealth Holdings Limited ("Titan Wealth"). Tavistock acts as Titan Wealth's retail distribution partner. TAM retains Titan Wealth as investment manager for the MPS.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUPUWACUPWGMQ
Date   Source Headline
8th Jan 20247:00 amRNSDirector/PDMR Shareholding
4th Jan 20249:33 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSInterim Results
1st Nov 202312:25 pmRNSResult of AGM
18th Oct 20234:58 pmRNSNotice of AGM
5th Oct 20237:00 amRNSTrading update and interim dividend declaration
20th Sep 20237:00 amRNSFinal Results for Year Ended 31 March 2023
28th Apr 20235:00 pmRNSTotal Voting Rights
11th Apr 20237:00 amRNSAcquisition of Precise Protect Limited
1st Mar 20237:00 amRNSTotal Voting Rights
16th Feb 20231:45 pmRNSExercise of Options and Total Voting Rights
10th Feb 20237:00 amRNSChange of Auditor
26th Jan 20237:00 amRNSDirector appointment
20th Dec 20227:00 amRNSInterim Results
1st Dec 20227:49 amRNSSale of LEBC Hummingbird Limited
30th Nov 20225:00 pmRNSTotal Voting Rights
22nd Nov 202212:30 pmRNSBuyback shares cancelled
18th Nov 20229:30 amRNSTransaction in Own Shares
4th Nov 202211:30 amRNSExercise of Options and Total Voting Rights
31st Oct 202212:00 pmRNSResult of AGM
6th Oct 20227:00 amRNSNotice of AGM
30th Sep 20225:00 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSPosting of Annual Report and Accounts
26th Sep 20227:00 amRNSFinal Results for Year Ended 31 March 2022
2nd Sep 202212:49 pmRNSExercise of Options and Total Voting Rights
31st Aug 20225:00 pmRNSTotal Voting Rights
24th Aug 20222:14 pmRNSBuyback shares cancelled
17th Aug 202210:41 amRNSTransaction in Own Shares
16th Aug 202210:14 amRNSDirector/PDMR Shareholding
26th Jul 202211:50 amRNSDirector/PDMR Shareholding
26th Jul 202210:33 amRNSDirector/PDMR Shareholding
12th Jul 20223:42 pmRNSHolding(s) in Company
12th Jul 20221:10 pmRNSHolding(s) in Company
4th Jul 202211:56 amRNSDirector/PDMR Shareholding
30th Jun 20226:29 pmRNSTotal Voting Rights
30th Jun 20222:20 pmRNSDirector/PDMR Shareholding
29th Jun 20222:22 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update and interim dividend declaration
23rd Jun 20222:04 pmRNSExercise of Options and Total Voting Rights
23rd May 20227:00 amRNSAcquisition of LEBC Hummingbird Limited
10th May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSCompletion of purchase of minority holding in LEBC
31st Mar 20225:00 pmRNSTotal Voting Rights
21st Mar 20227:00 amRNSTotal Voting Rights & AIM Rule 17
17th Mar 20227:00 amRNSHolding(s) in Company
28th Feb 202211:06 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.